This gradual decline in net price per prescription over time means that Goldman Sachs analysis of their obesity market forecast was ultimately right
Panels A, B, and C show the percentage of surviving hepatocytes for a 15 g dose, for an 18 g dose, and for a 30 g dose for males and females, respectively
Anti-diabetic medication (ADM) prescribing increased from December 2024 to January 2025, then remained relatively stable until March 2025
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols and covers the mechanism, evidence, and genetic context behind any decision to use them
Risk increases with: Too few calories or skipped meals , leading to protein breakdown for energy Inadequate protein intake , especially near minimal dietary requirements rather than weight-lossappropriate targets Lack of resistance training , removing the signal to maintain muscle Micronutrient deficiencies , such as low vitamin D, which can impair muscle function Preventing undernutrition dramatically reduces the risk of clinically meaningful muscle loss. How Common Is Lean-Mass Loss with GLP-1/GIP Therapy
The Core Rule: Prescription vs